DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the ROSSARI BIOTECH LIMITED (ROSSARI) share price today?

ROSSARI BIOTECH LIMITED (ROSSARI) is trading at ₹531.45 on the NSE, down 1.87% on the day. Source: DocStoX.

What is the PE ratio of ROSSARI BIOTECH LIMITED?

ROSSARI BIOTECH LIMITED has a price-to-earnings (PE) ratio of 19.7 in the Chemicals sector.

What is the market capitalisation of ROSSARI BIOTECH LIMITED?

ROSSARI BIOTECH LIMITED has a market capitalisation of approximately ₹2,950 crore.

ROSSARI BIOTECH LIMITED

ROSSARI·NSE·Chemicals

₹531.45▼ -10.10 (-1.87%)

Chemicals · Specialty Chemicals

A steady, established business

Day₹524.60

₹544.55

52W₹375

₹74642%

Open

₹542.00

High

₹544.55

Low

₹524.60

Prev Close

₹541.55

Volume

72.3K

VWAP

₹531.81

Snapshot

Key fundamentals

Market Cap

₹2,950 Cr

P/E Ratio

19.73Fair

P/B Ratio

2.17

EPS

₹26.94

Book Value

₹241.00

ROE

10.80%Average

ROCE

13.00%Decent

Dividend Yield

0.10%

Debt / Equity

0.33Moderate

Face Value

₹2.00

52W High

₹745.75

52W Low

₹375.00

Sector

Chemicals

Industry

Specialty Chemicals

Avoid

Narrow moatVery High uncertainty

Fair value estimate

₹266

▼ 50.0%downside

Trading at ₹531 — 50% above our estimate

BearFair valueBull

₹214₹266₹382

/100

Business quality — Watch the fundamentals

Growth 50Profitability 26Efficiency 13Valuation 80

Plain English

Our view

A steady, established business
Low debt relative to equity
Fundamental red flags (Piotroski 2/9)

Strengths

Low debt relative to equity
Promoters hold a controlling stake

Risks

Fundamental red flags (Piotroski 2/9)

How we got there

Fair value methods

Residual income

11% ROE fading to 14% over ~10 yrs, on ₹241 book

₹214

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹382

Analyst target

No analyst coverage

—

Blended fair value₹266

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Promoters hold a controlling stake

Bear case

Fundamental red flags (Piotroski 2/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

19.7Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

10.8%Average

Above 15% is considered healthy for Indian equities

ROCE

13.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.33Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹2,950 Cr

P/B

2.17

EPS

₹26.94

Div Yield

0.10%

What changed

Recent changes

Foreign investors-0.1% stake last quarter

What matters

News impact

Overview

Valuation

Reasonable

P/E 19.7×

Growth

Steady

+13% rev CAGR

Profitability

Modest

10.8% ROE

Financial health

Comfortable

D/E 0.33

Momentum

N/A

No technicals

Today

Trading activity

Delivery %53.6%

Turnover₹384.32L Cr

Trades3,686

VWAP₹531.81

Face value₹2.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+13.1%

+27.6%

10Y

+29.7%

Profit

+11.7%

+13.3%

10Y

+47.8%

EPS

+11.5%

+11.8%

10Y

+13.2%

Profile

Pros

Company's working capital requirements have reduced from 62.4 days to 48.6 days

Watch-outs

Cons

Company has a low return on equity of 12.0% over last 3 years.
Dividend payout has been low at 2.00% of profits over last 3 years

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Foreign investors sold 0.15 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

68%

Promoter

Promoters

68.2%-0.01

Public

10.1%+0.22

FII / FPI

2.2%-0.15

DII

18.2%-0.06

Others

1.4%

Total shareholders

86,972-2,277 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter68.15%

FII2.18%

DII18.20%

Public10.11%

Others1.36%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions